✦ LIBER ✦

249 LUMIRACOXIB IMPROVES PAIN AND FUNCTIONAL STATUS IN PATIENTS WITH PRIMARY HIP OSTEOARTHRITIS: A 13-WEEK, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, ACTIVE COMPARATOR TRIAL

✍ Scribed by T.J. Schnitzer; I.D. Dattani; B. Seriolo; H. Schneider; S. Yu; L. Tseng; R. Rebuli

Book ID: 114350397
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 47 KB
Volume: 15
Category: Article
ISSN: 1063-4584
DOI: 10.1016/s1063-4584(07)61881-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m

Manual therapy followed by specific acti

Manual therapy followed by specific active exercises versus a placebo followed by specific active exercises on the improvement of functional disability in patients with chronic non specific low back pain: a randomized controlled trial. Balthazard P, De Goumoens P, Rivier G, Demeulenaere P, Bellabeni P, Dériaz O. BMC Musculoskelet Disord 2012;13(1):162. [Epub ahead of print]

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB